Claris Lifesciences shines on getting Supplemental ANDA approval for Fluconazole Injection

21 Apr 2015 Evaluate

Claris Lifesciences is currently trading at Rs. 282.80, up by 8.40 points or 3.06 % from its previous closing of Rs. 274.40 on the BSE.

The scrip opened at Rs. 280.10 and has touched a high and low of Rs. 285.90 and Rs. 275.30 respectively. So far 790696 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 358.00 on 13-Apr-2015 and a 52 week low of Rs. 141.25 on 02-Jun-2014.

Last one week high and low of the scrip stood at Rs. 336.80 and Rs. 265.50 respectively. The current market cap of the company is Rs. 1542.09 crore.

The promoters holding in the company stood at 60.99% while Institutions and Non-Institutions held 24.79% and 14.22% respectively.

Claris Lifesciences has received the Supplemental Abbreviated New Drug Application (ANDA) approval for Fluconazole Injection in the United States of America (USA). The company currently marketing Fluconazole in 2 mg/ml formulation packed in 100 ml and 200 ml PVC Bags and now with the approval of supplemental ANDA, Claris is the only company to be able to sell Fluconazole in 50 ml variant in the US. By launching this variant Claris will be addressing the need of the medical fraternity.

Claris is one of the few injectables companies from India to have its own front end in the US, the company markets its products through its wholly owned subsidiary Claris Lifesciences Inc. The company has 13 ANDAs approved in its name across 8 molecules. The company has a under registration pipeline of 25 ANDAs across 22 molecules having an estimated addressable market size of $2.2 billion.

Claris manufactures and markets products across multiple delivery systems, markets, and therapeutic segments including anesthesia, blood products, anti-infectives, and plasma volume expanders. A significant majority of these products are generic drugs that are capable of being directly injected into the human body, which are predominantly used in the treatment of critical illnesses.

Peers
Company Name CMP
Redington 271.50
Adani Enterprises 2245.60
Amrapali Industries 15.56
Rashi Peripheral 329.50
PDS 353.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×